Literature DB >> 16374874

Biorelevant dissolution media: aggregation of amphiphiles and solubility of estradiol.

David Ilardia-Arana1, Henning G Kristensen, Anette Müllertz.   

Abstract

Biorelevant dissolution media containing bile salt and lecithin at concentrations appropriate for fed and fasted state are useful when testing oral solid formulations of poorly water-soluble drugs. Dilution of amphiphile solutions affects the aggregation state of the amphiphiles because bile salt is partitioned between the aqueous phase and the aggregates. The aim of the investigation was to study the effect of dilution on the size distribution of aggregates and its effect on the solubilization capacity. Clear buffered solutions of four intestinal amphiphiles (sodium glycocholate, lecithin, monoolein, and oleic acid) and a combination of these were prepared at high bile salt concentration. Micelles in the glycocholate solutions decreased in size when diluted. The addition of insoluble amphiphiles led to bigger micelles with no clear correlation between size of the micelles and amphiphile concentration. Dilution of the two- and four component media caused enlargement of the mixed micelles and formation of vesicles. The solubility of estradiol in the buffer solution was increased with addition of the amphiphiles. A good correlation (R(2) = 0.987) was found between estradiol solubility and mass concentration of the amphiphiles. The results demonstrate that, in the case of estradiol, the concentration of amphiphiles rather than the aggregation state determines the solubilization capacity of the medium. Copright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16374874     DOI: 10.1002/jps.20494

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs.

Authors:  Sarah Clarysse; Dimitrios Psachoulias; Joachim Brouwers; Jan Tack; Pieter Annaert; Guus Duchateau; Christos Reppas; Patrick Augustijns
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

2.  Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products.

Authors:  Dimitrios G Fatouros; Isabelle Walrand; Bjorn Bergenstahl; Anette Müllertz
Journal:  Pharm Res       Date:  2008-11-12       Impact factor: 4.200

3.  The Conformations of 17β-Estradiol (E2) and 17α-Estradiol as Determined by Solution NMR.

Authors:  Jianxin Guo; Richard I Duclos; V Kiran Vemuri; Alexandros Makriyannis
Journal:  Tetrahedron Lett       Date:  2010-07-07       Impact factor: 2.415

4.  Computational prediction of drug solubility in fasted simulated and aspirated human intestinal fluid.

Authors:  Jonas H Fagerberg; Eva Karlsson; Johan Ulander; Gunilla Hanisch; Christel A S Bergström
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

5.  Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design.

Authors:  Zhou Zhou; Claire Dunn; Ibrahim Khadra; Clive G Wilson; Gavin W Halbert
Journal:  Mol Pharm       Date:  2017-08-22       Impact factor: 4.939

6.  Topography of Simulated Intestinal Equilibrium Solubility.

Authors:  Claire Dunn; Jeremy Perrier; Ibrahim Khadra; Clive G Wilson; Gavin W Halbert
Journal:  Mol Pharm       Date:  2019-04-16       Impact factor: 4.939

7.  Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.

Authors:  Zhou Zhou; Claire Dunn; Ibrahim Khadra; Clive G Wilson; Gavin W Halbert
Journal:  Eur J Pharm Sci       Date:  2016-12-07       Impact factor: 4.384

8.  Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs.

Authors:  Jeremy Perrier; Zhou Zhou; Claire Dunn; Ibrahim Khadra; Clive G Wilson; Gavin Halbert
Journal:  Eur J Pharm Sci       Date:  2017-10-05       Impact factor: 4.384

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.